FDA Stem Cell Hearings — Who’s Pulling the Strings?
On April 10 and 11, the Food and Drug Administration (FDA) held its first hearings on embryonic stem cell research.
The transcript of what was said is not yet available. But the briefing document provided to the public is not at all reassuring. On the contrary, it seems to politicize the research and may even threaten to place manacles upon it.
There’s a good discussion of what is at stake here on Don Reed’s blog: www.stemcellbattles.com. Don is keeping his eye on this (and on so many other matters of urgent interest to patients!), and I expect he’ll tell us about any new developments.
